Barbara Jean Anne Bormann Kennedy Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

Barbara Jean Anne Bormann Kennedy is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 107,500 shares of XERS, which is worth approximately $363,350. The most recent transaction as insider was on Jun 05, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 108K

0% 3M change

86.96% 12M change

Total Value Held $363,350

BARBARA-JEAN ANNE BORMANN-KENNEDY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2024	BUY Grant, award, or other acquisition	-	50,000 Added 31.75%	107,500 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	42,500 Added 42.5%	57,500 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	$31,500 $2.1 p/Share	15,000 Added 50.0%	15,000 Common Stock

Also insider at

XERS

XERIS PHARMACEUTICALS INC Healthcare

Director

BAB